Philips Clinical & Medical Affairs Global
Clinical trials sponsored by Philips Clinical & Medical Affairs Global, explained in plain language.
The clinical and medical affairs division of Philips, a global health technology company.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New CT algorithm aims to clear up metal-related scan blur Results expected Sep 2026 (estimated)
- New CT tool aims to automate scan planning Results expected Sep 2026 (estimated)
- Laser zaps leg artery blockages in new trial Results expected Dec 2026 (estimated)
- AI-Powered heart scans could sharpen diagnosis Results expected Dec 2026 (estimated)
- AI clears up blurry CT scans for spine surgery patients Results expected Dec 2026 (estimated)